The Global Anhydrous Dibasic Calcium Phosphate market is estimated to be valued at US$ 245.96 Bn in 2024 and is expected to exhibit a CAGR of 7.9% over the forecast period from 2024 to 2030. Key TakeawaysKey players operating in the Anhydrous Dibasic Calcium Phosphate market include Pfizer, Sanofi, New England Biolabs, GlaxoSmithKline plc, GenScript, Thermo Fisher Scientific, Inc., Biogen,...
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian